Should you buy GMED stock?

Last updated:

Based on market data through , StockInvest.us rates Globus Medical Inc (GMED) as a Buy Candidate with a technical score of 3.42 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 5.69%
  • 3-month trend forecast Down 0.32%
  • Buy Candidate 3.42
AI Analysis AI Analysis of GMED AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add GMED to Watchlist?
Some Reasons Why To Add GMED:
  • Excellent financial health (Piotroski 7/9)
  • Beat earnings estimates in 3 of the last 4 quarters
  • Low bankruptcy risk (Altman Z-Score: 11.09)
PDF

Globus Medical Inc stock price up 4.61% on Monday
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Aug 04, 2026 Gain 5.69%

The Globus Medical Inc stock price gained 4.61% on the last trading day (Monday, 10th Aug 2026), rising from $82.35 to $86.15. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.00% from a day low at $81.40 to a day high of $86.28. The price has risen in 7 of the last 10 days and is up by 10.1% over the past 2 weeks. Volume fell on the last day by -656 thousand shares and in total, 3 million shares were bought and sold for approximately $227.72 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the wide and horizontal trend up. Breaks like this are often followed by swift and strong movements, and any correction down to the breakline at approximately. $86.12 is considered to be a "second chance" to hit a potential runner. It is, however, important that volume does follow the price as false breaks may appear and it may move back into the horizontal trend. Based on the rectangle-formation theory the stock is predicted to reach $96.97 sometime during the next 3 months.

GMED Signals & Forecast

Mostly positive signals in the chart today. The Globus Medical Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $81.70 and $79.59. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, July 23, 2026, and so far it has risen 14.23%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Thursday, July 23, 2026 and based on theory for this formation the price should go up by 0.120% to $86.25 within 24 trading days (Wednesday, August 26, 2026) since signal was issued.

Support, Risk & Stop-loss for Globus Medical Inc stock

Globus Medical Inc finds support from accumulated volume at $82.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $4.88 between high and low, or 6.00%. For the last week, the stock has had daily average volatility of 4.42%.

The Globus Medical Inc stock is extremely overbought on RSI14 (77). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $83.60 (-2.96%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 77 and this increases the risk substantially. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (GMED) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Globus Medical Inc to open at $84.61, and during the day (based on 14 day Average True Range), to move between $84.58 and $87.72, which gives a possible trading interval of +/-$3.14 (+/-3.72%) up or down from last closing price. If Globus Medical Inc takes out the full calculated possible swing range there will be an estimated 3.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $86.25 (0.12%) than the support at $82.35 (4.41%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Globus Medical Inc stock A Buy?

Several short-term signals are positive and the stock has broken the horizontal trend up, which indicates an even stronger rate of rising. We conclude that the current level may hold a buying opportunity as there is a fair chance for Globus Medical Inc stock to perform well in the short-term period.

Current score: 3.416 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $84.61 ( 1.79%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

GMED Performance

Trading levels for GMED

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 89.49 3.88%
R2 87.63 1.71%
R1 86.47 0.376%
Price 86.15
S1 82.75 -3.95%
S2 81.59 -5.29%
S3 79.73 -7.45%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 86.25 0.116%
Price 86.15
S1 82.35 -4.41%
S2 79.23 -8.03%
S3 76.64 -11.04%

FAQ

What is the symbol for Globus Medical Inc Stock and on which exchange is it traded?
The symbol for Globus Medical Inc is GMED and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Globus Medical Inc Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Globus Medical Inc (GMED) as a Buy Candidate with a technical score of 3.42 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Buy signal began on Aug 04, 2026, the price has risen 5.69%. The current 3-month trend forecast projects a fall of 0.32%.

How to buy Globus Medical Inc Stock?
Globus Medical Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Globus Medical Inc Stock.

What's the current price of Globus Medical Inc Stock?
As of the end of day on the Aug 10, 2026, the price of an Globus Medical Inc (GMED) share was $86.15.

What is the 52-week high and low for Globus Medical Inc Stock?
The 52-week high for Globus Medical Inc Stock is $101.40 and the 52-week low is $54.15.

What is the market capitalization of Globus Medical Inc Stock?
As of the Aug 10, 2026, the market capitalization of Globus Medical Inc is 11.619B.

When is the next earnings date for Globus Medical Inc?
The upcoming earnings date for Globus Medical Inc is Nov 05, 2026.
Click to get the best stock tips daily for free!
ABOUT GLOBUS MEDICAL INC
Globus Medical
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion p...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE